Daily Health Headlines

FDA Approves First Device to Prevent Migraines

👤by HealthDay 0 comments 🕔Wednesday, March 12th, 2014

TUESDAY, March 11, 2014 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday approved the first device aimed at preventing migraines.

The device, called Cefaly, is a headband-like device that runs on a battery and sits across the forehead and over the ears, the FDA said in a statement.

"The user positions the device in the center of the forehead, just above the eyes, using a self-adhesive electrode," the agency explained. "The device applies an electric current to the skin and underlying body tissues to stimulate branches of the trigeminal nerve, which has been associated with migraine headaches."

Cefaly is made by Belgium-based Cefaly Technology and is available by prescription only. The device is only indicated for use by adults and should only be used for 20 minutes per day, the FDA said. The agency also noted that "the user may feel a tingling or massaging sensation where the electrode is applied."

One migraine expert welcomed news of the device's approval.

"This device is a promising step forward in treating migraine headaches, as it addresses an important part of what we believe triggers and maintains a migraine attack," said Dr. Myrna Cardiel, clinical associate professor of neurology at NYU Langone Medical Center and NYU School of Medicine in New York City.

She added that the rate of positive response to the Cefaly device "appear to be comparable to what we see with most oral migraine preventive medications."

Millions of Americans are afflicted by migraines, which typically involve intense, throbbing pain in one side of the head, along with nausea, vomiting and a sensitivity to light and sound. According to the U.S. National Institutes of Health, about 10 percent of people worldwide complain of migraines, with women affected three times more often than men.

The FDA said Cefaly's approval was based on the results of a clinical trial in Belgium involving 67 people who had more than two migraine attacks per month and who had avoided medications in the three months prior to trying the device. Compared to people using an inactive placebo device, people who used Cefaly had "significantly fewer" days spent battling migraines compared to nonusers. They also had less need for migraine medications, the FDA said.

Approval was also based on a "patient satisfaction study" of more than 2,300 Cefaly users in Belgium and France. That study found that 53 percent of people who tried the device said they were satisfied with it and would buy one for continued use.

The cost of the device in the United States is not known yet, but it sells for about $300 in Canada, according to the company's Canadian website.

Some of the study participants did say they disliked the feeling of using the device. Others complained of sleepiness during the treatment session, and headache after the treatment, the FDA said. No serious side effects were reported.

-- E.J. Mundell

Article Credits / Source

HealthDay

HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Myrna Cardiel, M.D., clinical associate professor of neurology, NYU Langone Medical Center and NYU School of Medicine, New York City; U.S. Food and Drug Administration, news release, March 11, 2014

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Migraine Headaches Articles

Migraine and Stroke Risk Linked Again

Migraine and Stroke Risk Linked Again0

TUESDAY, Nov. 15, 2016 (HealthDay News) -- Women who experience migraines have more than double the risk of suffering a stroke, new research shows. The finding adds evidence to the suspected link between these two conditions. Although it's not ...

Study Questions Use of Migraine Meds in Kids, Teens

Study Questions Use of Migraine Meds in Kids, Teens0

THURSDAY, Oct. 27, 2016 (HealthDay News) -- A new study raises questions about the effectiveness of medicines commonly prescribed to prevent migraines in children and teens. The 24-week clinical trial involving 328 patients found no significant ...

More Kids and Teens Heading to ER With Headaches

More Kids and Teens Heading to ER With Headaches0

FRIDAY, Oct. 21, 2016 (HealthDay News) -- A growing number of American children with headaches are being seen at pediatric emergency departments and admitted to the hospital, researchers report. The researchers at the Children's Hospital of ...

Mouth and Gut Germs May Be Linked to Migraines

Mouth and Gut Germs May Be Linked to Migraines0

TUESDAY, Oct. 18, 2016 (HealthDay News) -- People with migraines have higher levels of certain microbes, or germs, in their mouths and digestive systems, new research suggests. Specifically, the analysis of data from the American Gut Project ...

For Migraine Sufferers, Is a Chiropractor's Touch All in the Mind?

For Migraine Sufferers, Is a Chiropractor's Touch All in the Mind?0

TUESDAY, Oct. 11, 2016 (HealthDay News) -- People with migraines sometimes seek a chiropractor for help, but a small study suggests that any pain relief they get might be a placebo effect. When researchers pitted real chiropractic manipulation ...

View More Migraine Headaches Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!